These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26304530)

  • 1. Management of pace-terminated ventricular arrhythmias.
    Pokorney SD; Al-Khatib SM
    Card Electrophysiol Clin; 2015 Sep; 7(3):497-513. PubMed ID: 26304530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T; Strauss M; Kouraki K; Zahn R
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.
    Sweeney MO; Sherfesee L; DeGroot PJ; Wathen MS; Wilkoff BL
    Heart Rhythm; 2010 Mar; 7(3):353-60. PubMed ID: 20185109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients.
    Kalra Y; Radbill AE; Johns JA; Fish FA; Kannankeril PJ
    Heart Rhythm; 2012 Nov; 9(11):1829-34. PubMed ID: 22766560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
    Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
    Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
    Grimm W; Plachta E; Maisch B
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
    Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ICD Therapies on Mortality in the OMNI Trial.
    Sun S; Johnson J; Degroot P; Brown ML; Obel O
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):192-9. PubMed ID: 26501695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators.
    Tuan TC; Lo MT; Lin YJ; Hsieh WH; Lin C; Huang NE; Lo LW; Chao TF; Liao JN; Hsieh YC; Wu TJ; Chen SA
    J Cardiovasc Electrophysiol; 2014 Apr; 25(4):411-417. PubMed ID: 24320556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging.
    Schoels W; Steinhaus D; Johnson WB; O'hara G; Schwab JO; Jenniskens I; Degroot PJ; Tang F; Helmling E;
    Heart Rhythm; 2007 Jul; 4(7):879-85. PubMed ID: 17599671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of appropriate implantable cardioverter-defibrillator therapy and implications for guideline-based driving restrictions.
    Kim MH; Zhang Y; Sakaguchi S; Goldberger JJ;
    Heart Rhythm; 2015 Aug; 12(8):1728-36. PubMed ID: 25933503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
    Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators.
    Rabinovich R; Muratore C; Iglesias R; Gonzalez M; Serafrica M; Sosa Liprandi A
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):133-6. PubMed ID: 7724386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators.
    Kouakam C; Lauwerier B; Klug D; Jarwe M; Marquié C; Lacroix D; Kacet S
    Am J Cardiol; 2003 Jul; 92(1):26-32. PubMed ID: 12842240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.
    Schuger C; Daubert JP; Zareba W; Rosero S; Yong P; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):399-403. PubMed ID: 33232811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.